Page last updated: 2024-08-24

glucose, (beta-d)-isomer and MODS

glucose, (beta-d)-isomer has been researched along with MODS in 113 studies

Research

Studies (113)

TimeframeStudies, this research(%)All Research%
pre-19906 (5.31)18.7374
1990's30 (26.55)18.2507
2000's51 (45.13)29.6817
2010's25 (22.12)24.3611
2020's1 (0.88)2.80

Authors

AuthorsStudies
Alexis, A; Carrer, DP; Giamarellos-Bourboulis, EJ; Kotsaki, A; Louis, K; Mylona, V; Netea, MG; Pistiki, A; Roditis, K; Savva, A; Van der Meer, JW1
Brown, GD; Engstad, R; Hoving, JC; Marakalala, MJ; Netea, MG; Williams, DL1
Goss, KL; Hilkin, BM; Hook, JS; Moreland, JG; Newell, EA; Whitmore, LC1
Huang, Z; Liu, C; Liu, S; Liu, Y; Pang, Q; Song, S; Wu, Q; Zhang, J; Zhang, R1
Guo, H; Liu, Q; Lu, J; Tian, G; Wang, H1
Jin, Y; Liu, Q; Lu, J; Lv, Y; Zhao, M1
Bai, XD; Hu, S; Li, JY; Li, YM; Wang, HB; Zhao, ZK; Zheng, JG1
Chen, W; Liu, C; Liu, S; Miao, R; Pang, Q; Song, S; Zhang, J; Zhou, Y1
Armstrong, MG; Hall, JV; Hoover, DB; Li, C; Monroe, LL; Ozment, TR; Williams, DL; Zhang, X1
Bramanti, P; Crisafulli, C; Cuzzocrea, S; Di Paola, R; Esposito, E; Genovese, T; Mazzon, E; Salvemini, D1
Dimitrova, P; Ivanovska, N1
Avsar, FM; Berkem, H; Guc, MO; Guler, G; Hengirmen, S; Iskit, AB; Ozel, H; Yuksel, BC1
Hou, L; Ji, G; Li, N; Li, S; Lu, Y; Ma, S; Peng, D; Qin, M; Shang, L; Xie, K; Xiong, L1
Bramanti, P; Cuzzocrea, S; Di Paola, R; Galuppo, M; Mazzon, E; Paterniti, I1
Li, ZH; Lu, JY; Lü, Y; Yang, Y; Zhao, M1
Hendriks, T; Joosten, LA; Kullberg, BJ; Netea, MG; van de Veerdonk, FL; van der Meer, JW; Verschueren, IC1
Hou, L; Ji, G; Li, J; Lu, Y; Mu, J; Peng, D; Shang, L; Xie, K; Xiong, L1
Hou, L; Liu, W; Pei, Y; Wang, G; Xie, K; Xiong, L; Yu, Y; Zhang, Z1
Guan, Y; Liu, M; Liu, X; Yang, Q; Zhang, L1
Bramanti, P; Cuzzocrea, S; Di Paola, R; Esposito, E; Impellizzeri, D; Mazzon, E1
Ashton, SH; Borg, KT; Cook, JA; Fan, H; Halushka, PV; Wong, D1
Capuano, A; Cuzzocrea, S; Di Palma, D; Donniacuo, M; Esposito, E; Mazzon, E; Paterniti, I; Rinaldi, B; Rossi, F; Sodano, L1
Aloisi, C; Cuzzocrea, S; Galuppo, M; Italiano, D; Mazzon, E; Mondello, P; Mondello, S1
Capuano, A; Cuzzocrea, S; Di Palma, D; Di Paola, R; Donniacuo, M; Imperatore, F; Mazzon, E; Rinaldi, B; Rossi, F; Sodano, L1
Bramanti, P; Cuzzocrea, S; Di Paola, R; Impellizzeri, D; Mazzon, E; Paterniti, I1
Bruscoli, S; Cuzzocrea, S; Di Paola, R; Esposito, E; Galuppo, M; Mazzon, E; Nocentini, G; Riccardi, C; Riccardi, L; Ronchetti, S1
Kang, JR; Li, F; Lu, JY; Tian, G; Wang, HW; Wang, XH; Yang, W; Yang, Y1
Guo, H; Li, F; Liu, Q; Lu, JY; Wang, HW1
Goris, RJ; Hendriks, T; van de Loo, FA; van der Jagt, M; Volman, TJ1
Barbera, A; Caputi, AP; Centorrino, T; Chatterjee, PK; Ciccolo, A; Cuzzocrea, S; Dugo, L; Fulia, F; Mazzon, E; McDonald, MC; Serraino, I; Thiemermann, C1
Hristova, M; Ivanovska, N; Yordanov, M1
Lan, C; Tang, CW1
Hu, S; Jiang, XG; Jin, H; Li, JY; Lu, JY; Lü, Y; Sheng, ZY; Zhang, R1
Hu, S; Lu, JY; Sun, Y; Tong, X; Wang, XH; Yang, Y1
Caputi, AP; Chatterjee, PK; Cuzzocrea, E; Cuzzocrea, S; Di Paola, R; Fulia, F; Genovese, T; Ianaro, A; Patel, NS; Pisano, B; Rossi, A; Sautebin, L; Thiemermann, C1
Senftleben, U1
Blask, D; Dauchy, R; Dietz, PA; Lynch, D; Reynolds, FD; Zuckerman, R1
Caputi, AP; Cuzzocrea, E; Cuzzocrea, S; Di Paola, R; Dugo, L; Fulia, F; Genovese, T; Mazzon, E; Salvemini, D; Serraino, I1
Caputi, AP; Chatterjee, PK; Cuzzocrea, E; Cuzzocrea, S; Di Paola, R; Di Rosa, M; Dugo, L; Fulia, F; Genovese, T; Ianaro, A; Patel, NS; Pisano, B; Thiemermann, C1
Caputi, AP; Cuzzocrea, S; De Angelis, A; Filippelli, A; Imperatore, F; Liguori, G; Luongo, C; Rossi, F; Scafuro, A1
Caputi, AP; Catalano, P; Cuzzocrea, S; Di Paola, R; Genovese, T; Li, JH; Massuda, E; Xu, W; Zhang, J1
Goris, RJ; Hendriks, T; van der Meer, JW; Volman, TJ1
Britti, D; Caputi, AP; Cuzzocrea, S; De Sarro, A; Di Paola, R; Dugo, L; Genovese, T; Rossi, A; Sautebin, L; Sciarra, G; Serraino, I1
DeGroot, J; Goris, RJ; Hendriks, T; Lomme, RM; Verhofstad, AA; Volman, TJ1
Pallister, I; Topley, N1
Lan, C; Liu, R; Tang, CW1
Goris, RJ; Hendriks, T; Volman, TJ2
Guc, MO; Guler, G; Iskit, AB; Korkmaz, A; Rasa, K; Tanriverdi, P; Yuksel, BC1
Marshall, JC1
Phelps, DS; Thomas, NJ; Umstead, TM1
Lan, C; Liu, R; Tang, C; Wang, C1
Autore, G; Britti, D; Cuzzocrea, S; Di Paola, R; Genovese, T; Marzocco, S; Mazzon, E; Pinto, A1
Chen, XM; Du, XG1
Abouhamze, A; Efron, PA; Hutchins, B; LaFace, D; McAuliffe, PF; Moldawer, LL; Murday, ME; Scumpia, PO; Tannahill, CL; Ungaro, R1
Qian, X; Wang, S; Xu, B; Xue, Q; Yang, J; Yin, T; Zhu, Q1
Crisafulli, C; Cuzzocrea, S; Di Bella, P; Di Paola, R; Esposito, E; Genovese, T; Mazzon, E; Meli, R; Menegazzi, M; Muià, C; Suzuki, H1
Chouker, A; Hoelzl, A; Hummel, T; Kaufmann, I; Peter, K; Schliephake, F; Thiel, M1
Capuano, A; Cuzzocrea, S; De Lucia, D; Filippelli, A; Imperatore, F; Liguori, G; Rinaldi, B; Rossi, F; Sessa, M1
Crisafulli, C; Cuzzocrea, S; Di Paola, R; Esposito, E; Genovese, T; Malleo, G; Mazzon, E; Meli, R; Muià, C; Sessa, E1
Thiemermann, C1
Li, L; Lu, JY; Tian, G; Wang, HW; Wang, XH; Yang, Y1
Caminiti, R; Cuzzocrea, S; Di Bella, P; Di Paola, R; Esposito, E; Genovese, T; Malleo, G; Mazzon, E; Muià, C1
Bramanti, P; Caminiti, R; Cuzzocrea, S; Di Paola, R; Esposito, E; Genovese, T; Malleo, G; Mazzon, E1
Gilligan, L; Johnson, KJ; Rodriguez, JL; Shayevitz, JR; Tait, AR1
Goris, RJ; Hendriks, T; Meyer, MP; Nieuwenhuijzen, GA1
Consalvo, M; De Gaudio, AR; Di Filippo, A; Novelli, GP; Paternostro, E; Pellegrini, G; Scardi, S1
Chaudry, IH; Deitch, EA; Ertel, W; Mainous, MR1
Goris, RJ; Hendriks, T; Jansen, MJ; van der Meer, JW; Vogels, MT1
Dwenger, A; Grotz, M; Gruner, A; Jochum, M; Pape, HC; Regel, G; Remmers, D; Scharff, H1
Goris, RJ; Hendriks, T; Huyben, CM; Jansen, MJ; Tax, WJ; van der Meer, JW1
Corstens, FH; Goris, RJ; Hendriks, T; Knapen, MF; Nieuwenhuijzen, GA; Oyen, WJ1
Cook, DN; Kotwal, GJ; Miller, CG1
Goris, RJ; Hendriks, T; Knapen, MF; Nieuwenhuijzen, GA; van Rooijen, N1
Cuzzocrea, S; Flower, RJ; Getting, SJ; Lim, LH; Perretti, M; Salzman, AL; Szabó, C; Zingarelli, B1
Calapai, G; Campo, GM; Caputi, AP; Costantino, G; Crisafulli, C; Cuzzocrea, S; Di Rosa, M; Nava, F; Rizzo, A; Sautebin, L; Zingarelli, B1
Geeraedts, LM; Goris, RJ; Hendriks, T; Jansen, MJ; Lange, W; Verhofstad, AA1
Chiara, O; Fattori, L; Padalino, P; Ravizzini, C; Tiberio, G; Turconi, MG1
Goris, RJ; Hendriks, T; Jansen, MJ; Knapen, MF; van der Meer, JW; van Kempen, LC1
Dwenger, A; Grotz, M; Pape, HC; Remmers, D; Tscherne, H; Vaske, R; Wisner, D1
Bridges, CD; Cone, JB; Ferrer, TJ; Palmer, HE; Robertson, RD; Wallace, BH; Webb, JW1
Goris, RJ; Hendriks, T; Hermsen, R; Jansen, MJ; Van der Meer, JW1
Caputi, AP; Ciriaco, E; Costantino, G; Cuzzocrea, S; de Sarro, A; de Sarro, G; Laurà, R; Mazzon, E1
Caputi, AP; Costantino, G; Cuzzocrea, S; Mazzon, E1
Caputi, AP; Costantino, G; Cuzzocrea, S; Sottile, A; Teti, D; Zingarelli, B1
de Man, BM; Goris, RJ; Hendriks, T; Jansen, MJ; van der Meer, JW1
Cheadle, WG; Daly, J; Kotwal, GJ; Mahesh, J1
Caputi, AP; Costantino, G; Cuzzocrea, S; Filippelli, A; Imperatore, F; Luongo, C; Mangoni, G; Mazzon, E; Rossi, F; Scafuro, MA1
Jackson, RJ; Johnson, DD; Maxson, RT; Smith, SD; Thomas, R1
Burdon, D; Pfeffer, K; Tiedje, T; Vollmer, E; Zabel, P1
Carcillo, JA; Herzer, WA; Jackson, EK; Mi, Z; Thomas, NJ1
Caputi, AP; Centorrino, T; Ciccolo, A; Cuzzocrea, S; Filipe, HM; Lepore, V; Mazzon, E; McDonald, MC; Terranova, ML; Thiemermann, C1
deBoisblanc, B; Kantrow, SP; Taylor, DE1
Barbera, A; Caputi, AP; Centorrino, T; Ciccolo, A; Cuzzocrea, S; Dugo, L; Fonti, MT; Mazzon, E1
Andersson, R; Deng, X; Lasson, A; Soltesz, V; Sun, TZ; Wang, X1
Chen, H; Guan, F; Wu, X1
Goris, RJ; Hendriks, T; Kullberg, BJ; Verhofstad, AA; Volman, TJ1
Caputi, AP; Chatterjee, PK; Cuzzocrea, S; Dugo, L; Fulia, F; Mazzon, E; McDonald, MC; Paola, RD; Thiemermann, C1
Goris, RJ; Koldewijn, EL; Lieners, CF; Redl, H; van Bebber, IP1
Lu, JY2
Goris, RJ; Koopman, JP; Mollen, RM; van Bebber, IP1
Berg, RD; Deitch, EA; Ma, L; Ma, WJ; Specian, RD1
Bahrami, S; Goris, RJ; Lieners, C; Redl, H; Schlag, G; van Bebber, IP1
Bahrami, S; Boekholz, WK; Dinges, HP; Goris, RJ; Redl, H; Schillings, PH; Schlag, G; van Bebber, IP1
Baxter, J; Bitzer, L; Flynn, W; Gutierrez, C; Kelley, K; Lalka, D; Sands, A; Sharma, P; Steinberg, S; van Liew, J1
Goris, RJ; Schillings, PH; Speekenbrink, RG; van Bebber, IP1
Betti, S; Borrelli, E; Chiara, O; Giomarelli, PP; Nespoli, A; Padalino, P1
Fry, DE; Naff, GB; Schirmer, JM; Schirmer, WJ1
Boekholtz, WK; Goris, RJ; Nuytinck, JK; Schillings, PH; van Bebber, IP1
Aboudara, M; Akin, EE; Ambery, P; Barroso, WKS; Berwanger, O; Buenconsejo, J; Chopra, V; Esterline, R; Feitosa, ADM; Fonseca, A; Furtado, RHM; Garla, V; Gasparyan, SB; Gordon, RA; Gosch, K; Hoffmann Filho, CR; Jaeger, CP; Javaheri, A; Koch, GG; Kosiborod, MN; Langkilde, AM; Lazcano Soto, JR; Leaes, PE; Martinez, F; Moia, DDF; Mukhtar, O; Nassif, M; Nigro Maia, L; Oscarsson, J; Pursley, M; Silveira, FS; Soares, RVP; Tang, F; Verma, S; Windsor, SL1
Cai, S; Chen, Z; Gao, Y; Li, T; Xu, S; Zeng, Z; Zhang, J; Zhao, KS1
Huang, QB1

Reviews

3 review(s) available for glucose, (beta-d)-isomer and MODS

ArticleYear
NF-kappaB in critical diseases: a bad guy?
    Intensive care medicine, 2003, Volume: 29, Issue:11

    Topics: Animals; Antioxidants; Critical Illness; Disease Models, Animal; Gene Expression Regulation; Homeostasis; Humans; Inflammation; Mice; Multiple Organ Failure; NF-kappa B; Oxidation-Reduction; Proline; Signal Transduction; Thiocarbamates; Time Factors; Transcription Factors; Zymosan

2003
Zymosan-induced generalized inflammation: experimental studies into mechanisms leading to multiple organ dysfunction syndrome.
    Shock (Augusta, Ga.), 2005, Volume: 23, Issue:4

    Topics: Animals; Complement System Proteins; Cytokines; Disease Models, Animal; Humans; Inflammation; Mice; Models, Biological; Multiple Organ Failure; Oxidants; Rats; Time Factors; Zymosan

2005
Classical corticosteroids and new lipid peroxidation inhibitors in the therapy of multiple organ failure (MOF).
    Minerva chirurgica, 1997, Volume: 52, Issue:9

    Topics: Adrenal Cortex Hormones; Animals; Anti-Inflammatory Agents; Antioxidants; Clinical Trials as Topic; Free Radical Scavengers; Humans; Injections, Intraperitoneal; Lipid Peroxidation; Methylprednisolone; Multiple Organ Failure; Pregnatrienes; Prospective Studies; Rabbits; Randomized Controlled Trials as Topic; Respiratory Distress Syndrome; Sepsis; Shock, Septic; Zymosan

1997

Trials

1 trial(s) available for glucose, (beta-d)-isomer and MODS

ArticleYear
Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial.
    The lancet. Diabetes & endocrinology, 2021, Volume: 9, Issue:9

    Topics: Aged; Benzhydryl Compounds; Cardiometabolic Risk Factors; COVID-19; Double-Blind Method; Female; Glucosides; Humans; Male; Middle Aged; Multiple Organ Failure; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome

2021

Other Studies

109 other study(ies) available for glucose, (beta-d)-isomer and MODS

ArticleYear
Bacterial translocation in an experimental model of multiple organ dysfunctions.
    The Journal of surgical research, 2013, Volume: 183, Issue:2

    Topics: Animals; Bacterial Translocation; Disease Models, Animal; Enterobacteriaceae; Enterococcus; Interferon-gamma; Interleukin-10; Interleukin-17; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Multiple Organ Failure; Spleen; Zymosan

2013
Dectin-1 plays a redundant role in the immunomodulatory activities of β-glucan-rich ligands in vivo.
    Microbes and infection, 2013, Volume: 15, Issue:6-7

    Topics: Animals; Disease Models, Animal; Glucans; Lectins, C-Type; Ligands; Mice; Multiple Organ Failure; Staphylococcal Infections; Staphylococcus aureus; Zymosan

2013
NOX2 protects against progressive lung injury and multiple organ dysfunction syndrome.
    American journal of physiology. Lung cellular and molecular physiology, 2014, Jul-01, Volume: 307, Issue:1

    Topics: Animals; Bone Marrow Cells; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Lung; Lung Injury; Macrophage Activation; Macrophages; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Multiple Organ Failure; NADPH Oxidase 2; NADPH Oxidases; Neutrophil Infiltration; Systemic Inflammatory Response Syndrome; Zymosan

2014
Role of Serotonin in MODS: Deficiency of Serotonin Protects Against Zymosan-Induced Multiple Organ Failure in Mice.
    Shock (Augusta, Ga.), 2015, Volume: 43, Issue:3

    Topics: 5-Hydroxytryptophan; Animals; Cytokines; Disease Models, Animal; Enzyme Inhibitors; Fenclonine; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Multiple Organ Failure; Oxidative Stress; Peritonitis; Protective Agents; Serotonin; Shock; Tryptophan Hydroxylase; Zymosan

2015
Protective effect of Flt3L on organ structure during advanced multiorgan dysfunction syndrome in mice.
    Molecular medicine reports, 2015, Volume: 11, Issue:6

    Topics: Adjuvants, Immunologic; Animals; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Male; Membrane Proteins; Mice, Inbred C57BL; Multiple Organ Failure; Zymosan

2015
PD-L1 blockade improves immune dysfunction of spleen dendritic cells and T-cells in zymosan-induced multiple organs dysfunction syndromes.
    International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:2

    Topics: Animals; B7-H1 Antigen; Cell Proliferation; Cytokines; Dendritic Cells; Lymphocyte Activation; Mice; Multiple Organ Failure; Spleen; T-Lymphocytes; Zymosan

2015
Dimethyl sulfoxide inhibits zymosan-induced intestinal inflammation and barrier dysfunction.
    World journal of gastroenterology, 2015, Oct-14, Volume: 21, Issue:38

    Topics: Amine Oxidase (Copper-Containing); Animals; Apoptosis; Dimethyl Sulfoxide; Enteritis; Free Radical Scavengers; Interleukin-10; Intestinal Mucosa; Male; Malondialdehyde; Multiple Organ Failure; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Superoxide Dismutase; Systemic Inflammatory Response Syndrome; Tight Junctions; Tumor Necrosis Factor-alpha; Zonula Occludens-1 Protein; Zymosan

2015
THE PROTECTIVE ROLE OF CURCUMIN IN ZYMOSAN-INDUCED MULTIPLE ORGAN DYSFUNCTION SYNDROME IN MICE.
    Shock (Augusta, Ga.), 2016, Volume: 45, Issue:2

    Topics: Animals; Anti-Infective Agents; Curcumin; Inflammation; Male; Mice; Mice, Inbred C57BL; Multiple Organ Failure; Zymosan

2016
Zymosan-Induced Peritonitis: Effects on Cardiac Function, Temperature Regulation, Translocation of Bacteria, and Role of Dectin-1.
    Shock (Augusta, Ga.), 2016, Volume: 46, Issue:6

    Topics: Alarmins; Animals; Disease Models, Animal; Inflammation; Lectins, C-Type; Male; Mice; Mice, Knockout; Multiple Organ Failure; Peritonitis; Receptors, Pattern Recognition; Zymosan

2016
Fumonisin b1 reduces the development of multiple organ failure induced by zymosan in mice.
    Shock (Augusta, Ga.), 2009, Volume: 31, Issue:2

    Topics: Animals; Cytokines; Fumonisins; Immunohistochemistry; Inflammation; Male; Mice; Multiple Organ Failure; Nitric Oxide; Peritonitis; Peroxidase; Shock; Time Factors; Treatment Outcome; Zymosan

2009
Tyrphostin AG-490 inhibited the acute phase of zymosan-induced inflammation.
    International immunopharmacology, 2008, Volume: 8, Issue:11

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Bilirubin; Creatinine; Inflammation; Interleukin-6; Macrophages; Male; Mice; Multiple Organ Failure; Nitric Oxide; Nitric Oxide Synthase Type II; Protein Kinase Inhibitors; STAT Transcription Factors; Tumor Necrosis Factor-alpha; Tyrphostins; Whole Blood Coagulation Time; Zymosan

2008
The effects of L-NG-nitroarginine in a zymosan-induced multiple organ dysfunction syndrome model.
    European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes, 2009, Volume: 43, Issue:2

    Topics: Animals; Disease Models, Animal; Enzyme Inhibitors; Kidney; Male; Mice; Multiple Organ Failure; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Pancreas; Splanchnic Circulation; Zymosan

2009
Effects of reactive oxygen species scavenger on the protective action of 100% oxygen treatment against sterile inflammation in mice.
    Shock (Augusta, Ga.), 2010, Volume: 33, Issue:6

    Topics: Acetylcysteine; Animals; Antioxidants; Ascorbic Acid; Cytokines; Free Radical Scavengers; Heart; Inflammation; Kidney; Liver; Lung; Male; Mice; Multiple Organ Failure; Myocardium; Oxygen; Reactive Oxygen Species; Sepsis; Thiourea; Zymosan

2010
PD98059, a specific MAP kinase inhibitor, attenuates multiple organ dysfunction syndrome/failure (MODS) induced by zymosan in mice.
    Pharmacological research, 2010, Volume: 61, Issue:2

    Topics: Acute Disease; Animals; Apoptosis; bcl-2-Associated X Protein; Cell Adhesion Molecules; Cytokines; Fas Ligand Protein; Flavonoids; I-kappa B Proteins; Inflammation Mediators; Male; Mice; Mitogen-Activated Protein Kinases; Multiple Organ Failure; Neutrophil Infiltration; NF-KappaB Inhibitor alpha; Nitric Oxide; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Peritonitis; Phosphorylation; Poly(ADP-ribose) Polymerases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Systemic Inflammatory Response Syndrome; Time Factors; Transcription Factor RelA; Tyrosine; Zymosan

2010
Relationship between HMGB1 content and MHC-II expression in circulating monocytes and spleen of mice challenged with zymosan.
    Chinese journal of traumatology = Zhonghua chuang shang za zhi, 2009, Volume: 12, Issue:6

    Topics: Animals; Histocompatibility Antigens Class II; HMGB1 Protein; Male; Mice; Mice, Inbred C57BL; Monocytes; Multiple Organ Failure; Spleen; Zymosan

2009
Differential effects of IL-17 pathway in disseminated candidiasis and zymosan-induced multiple organ failure.
    Shock (Augusta, Ga.), 2010, Volume: 34, Issue:4

    Topics: Animals; Candidiasis; Enzyme-Linked Immunosorbent Assay; Interferon-gamma; Interleukin-10; Interleukin-17; Mice; Mice, Knockout; Multiple Organ Failure; Phagocytosis; Signal Transduction; Tumor Necrosis Factor-alpha; Zymosan

2010
Subanesthetic dose of isoflurane protects against zymosan-induced generalized inflammation and its associated acute lung injury in mice.
    Shock (Augusta, Ga.), 2010, Volume: 34, Issue:2

    Topics: Acute Lung Injury; Amitrole; Animals; Catalase; Inflammation; Isoflurane; Male; Mice; Multiple Organ Failure; Oxidative Stress; Superoxide Dismutase; Zymosan

2010
Hydrogen gas improves survival rate and organ damage in zymosan-induced generalized inflammation model.
    Shock (Augusta, Ga.), 2010, Volume: 34, Issue:5

    Topics: Administration, Inhalation; Animals; Antioxidants; Biomarkers; Cytokines; Dinoprost; Drug Evaluation, Preclinical; Gases; HMGB1 Protein; Hydrogen; Inflammation; Male; Mice; Mice, Inbred ICR; Multiple Organ Failure; Oxidation-Reduction; Superoxide Dismutase; Viscera; Zymosan

2010
Ulinastatin-mediated protection against zymosan-induced multiple organ dysfunction in rats.
    Biologicals : journal of the International Association of Biological Standardization, 2010, Volume: 38, Issue:5

    Topics: Animals; Cytoprotection; Female; Glycoproteins; Intercellular Adhesion Molecule-1; Kidney; Liver; Lung; Male; Multiple Organ Failure; Rats; Rats, Wistar; Survival Analysis; Toll-Like Receptor 4; Trypsin Inhibitors; Tumor Necrosis Factor-alpha; Zymosan

2010
Olprinone, a specific phosphodiesterase (PDE)-III inhibitor, reduces the development of multiple organ dysfunction syndrome in mice.
    Pharmacological research, 2011, Volume: 64, Issue:1

    Topics: Alanine Transaminase; Alkaline Phosphatase; Amylases; Animals; Apoptosis; Ascitic Fluid; Aspartate Aminotransferases; bcl-2-Associated X Protein; Bicarbonates; Bilirubin; Blood Gas Analysis; Body Weight; Cell Count; Creatinine; Fas Ligand Protein; Hydrogen-Ion Concentration; Imidazoles; Intercellular Adhesion Molecule-1; Interleukin-1beta; Kidney; Lipase; Liver; Lung; Male; Mice; Mice, Inbred Strains; Multiple Organ Failure; Nitrates; Nitrites; P-Selectin; Pancreas; Phosphodiesterase 3 Inhibitors; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Pyridones; Survival Analysis; Tumor Necrosis Factor-alpha; Tyrosine; Zymosan

2011
Beneficial effect of a CXCR4 agonist in murine models of systemic inflammation.
    Inflammation, 2012, Volume: 35, Issue:1

    Topics: Animals; Chemokine CXCL12; Disease Models, Animal; Endotoxemia; Interleukin-10; Interleukin-6; Lipopolysaccharides; Macrophages; Male; Mice; Multiple Organ Failure; Receptors, CXCR4; Sepsis; Systemic Inflammatory Response Syndrome; Tumor Necrosis Factor-alpha; Zymosan

2012
PPARα mediates the anti-inflammatory effect of simvastatin in an experimental model of zymosan-induced multiple organ failure.
    British journal of pharmacology, 2011, Volume: 163, Issue:3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Interleukin-1beta; Intestinal Mucosa; Intestines; Kidney; Liver; Lung; Mice; Mice, Knockout; Multiple Organ Failure; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; PPAR alpha; Shock; Simvastatin; Tumor Necrosis Factor-alpha; Up-Regulation; Zymosan

2011
Glutamine treatment attenuates the development of organ injury induced by zymosan administration in mice.
    European journal of pharmacology, 2011, May-01, Volume: 658, Issue:1

    Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Body Weight; Cytokines; Enzyme Activation; Fas Ligand Protein; Gene Expression Regulation; Glutamine; Inflammation; Lipid Peroxidation; Male; Mice; Multiple Organ Failure; Neutrophil Infiltration; Nitric Oxide; Peritoneal Cavity; Poly Adenosine Diphosphate Ribose; Poly(ADP-ribose) Polymerases; Protein Transport; Proto-Oncogene Proteins c-bcl-2; Tyrosine; Zymosan

2011
Hyperbaric oxygen therapy reduces the toll-like receptor signaling pathway in multiple organ failures.
    Intensive care medicine, 2011, Volume: 37, Issue:7

    Topics: Analysis of Variance; Animals; Blotting, Western; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Hyperbaric Oxygenation; Immunohistochemistry; Interleukin-1beta; Male; Multiple Organ Failure; Random Allocation; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Toll-Like Receptors; Tumor Necrosis Factor-alpha; Zymosan

2011
Effect of NADPH-oxidase inhibitors in the experimental model of zymosan-induced shock in mice.
    Free radical research, 2011, Volume: 45, Issue:7

    Topics: Acetophenones; Animals; Apoptosis; Cytokines; Enzyme Inhibitors; Male; Mice; Multiple Organ Failure; NADPH Oxidases; Nitrates; Nitrites; Onium Compounds; Reactive Oxygen Species; Shock; Systemic Inflammatory Response Syndrome; Zymosan

2011
GITR gene deletion and GITR-FC soluble protein administration inhibit multiple organ failure induced by zymosan.
    Shock (Augusta, Ga.), 2011, Volume: 36, Issue:3

    Topics: Animals; Cell Adhesion Molecules; Gene Deletion; Glucocorticoid-Induced TNFR-Related Protein; Immunohistochemistry; Interleukin-1beta; Interleukin-6; Male; Mice; Mice, Knockout; Multiple Organ Failure; Nitrates; Nitrites; Peroxidase; Recombinant Fusion Proteins; Tumor Necrosis Factor-alpha; Zymosan

2011
Treatment with Fms-like tyrosine kinase 3 ligand reverses lung dendritic cell immunoparalysis and ameliorates zymosan-induced secondary lung injury in mice.
    Clinical and experimental immunology, 2012, Volume: 170, Issue:2

    Topics: Animals; Antigens, CD; Body Weight; Dendritic Cells; fms-Like Tyrosine Kinase 3; Interleukin-10; Interleukin-12; Ligands; Lung; Lung Injury; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Multiple Organ Failure; Survival Rate; Zymosan

2012
Altered MARCH1 ubiquination-regulated dendritic cell immune functions during the early stage of zymosan-induced multiple organ dysfunction syndrome (MODS) in mice.
    Immunology letters, 2013, Volume: 150, Issue:1-2

    Topics: Animals; CD11c Antigen; Dendritic Cells; Disease Models, Animal; Disease Progression; Gene Expression; Histocompatibility Antigens Class II; Lymphocyte Activation; Male; Mice; Multiple Organ Failure; Proteasome Endopeptidase Complex; Proteolysis; RNA Interference; Spleen; T-Lymphocytes; Ubiquitin-Protein Ligases; Ubiquitination; Zymosan

2013
Organ damage in zymosan-induced multiple organ dysfunction syndrome in mice is not mediated by inducible nitric oxide synthase.
    Critical care medicine, 2002, Volume: 30, Issue:7

    Topics: Animals; Guanidines; Mice; Mice, Inbred C57BL; Multiple Organ Failure; Nitric Oxide Synthase; Random Allocation; Zymosan

2002
Effects of calpain inhibitor I on multiple organ failure induced by zymosan in the rat.
    Critical care medicine, 2002, Volume: 30, Issue:10

    Topics: Animals; Calpain; Cell Movement; Cyclooxygenase 2; Dose-Response Relationship, Drug; Glycoproteins; Immunohistochemistry; Intestinal Mucosa; Intestines; Isoenzymes; Liver; Lung; Male; Malondialdehyde; Multiple Organ Failure; Neutrophils; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peritoneum; Peritonitis; Peroxidase; Peroxynitrous Acid; Poly Adenosine Diphosphate Ribose; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Tyrosine; Zymosan

2002
Effect of fangchinoline in murine models of multiple organ dysfunction syndrome and septic shock.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2003, Volume: 52, Issue:1

    Topics: Alkaline Phosphatase; Alkaloids; Animals; Benzylisoquinolines; Complement System Proteins; Escherichia coli Infections; Liver; Macrophages, Peritoneal; Male; Mice; Mice, Inbred ICR; Multiple Organ Failure; Organ Size; Shock, Septic; Spleen; Time Factors; Tumor Necrosis Factor-alpha; Zymosan

2003
[Increasing activity of the intestinal mucosal mast cells in rats with multiple organ failure].
    Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue, 2003, Volume: 15, Issue:1

    Topics: Animals; Female; Histamine; Intestinal Mucosa; Mast Cells; Multiple Organ Failure; Rats; Tumor Necrosis Factor-alpha; Zymosan

2003
[A small dose of intraperitoneal injection of zymosan induces systemic inflammatory response and multiple organ dysfunction following gut ischemia-reperfusion injury].
    Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue, 2003, Volume: 15, Issue:1

    Topics: Animals; Disease Models, Animal; Male; Multiple Organ Failure; Rats; Rats, Wistar; Reperfusion Injury; Systemic Inflammatory Response Syndrome; Zymosan

2003
[Replication of animal model and pathological study of delayed multiple organ dysfunction syndrome in mice].
    Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue, 2003, Volume: 15, Issue:1

    Topics: Animals; Disease Models, Animal; Male; Mice; Mice, Inbred Strains; Multiple Organ Failure; Zymosan

2003
Pyrrolidine dithiocarbamate attenuates the development of organ failure induced by zymosan in mice.
    Intensive care medicine, 2003, Volume: 29, Issue:11

    Topics: Animals; Antioxidants; Blotting, Western; Chemotaxis, Leukocyte; Disease Models, Animal; Drug Evaluation, Preclinical; Immunohistochemistry; Lipid Peroxidation; Male; Malondialdehyde; Mice; Mice, Inbred Strains; Multiple Organ Failure; Neutrophils; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peroxidase; Poly(ADP-ribose) Polymerases; Pyrrolidines; Random Allocation; Thiocarbamates; Time Factors; Tyrosine; Zymosan

2003
The pineal gland hormone melatonin improves survival in a rat model of sepsis/shock induced by zymosan A.
    Surgery, 2003, Volume: 134, Issue:3

    Topics: Animals; Disease Models, Animal; Male; Melatonin; Multiple Organ Failure; Rats; Rats, Sprague-Dawley; Sepsis; Shock; Zymosan

2003
Protective effects of M40401, a selective superoxide dismutase mimetic, on zymosan-induced nonseptic shock.
    Critical care medicine, 2004, Volume: 32, Issue:1

    Topics: Animals; Disease Models, Animal; Immunohistochemistry; Intestines; Lipid Peroxidation; Lung; Male; Multiple Organ Failure; Organometallic Compounds; Probability; Protective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Risk Assessment; Sensitivity and Specificity; Shock; Statistics, Nonparametric; Superoxide Dismutase; Zymosan

2004
Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces the development of nonseptic shock induced by zymosan in mice.
    Critical care medicine, 2004, Volume: 32, Issue:2

    Topics: Animals; Lipid Peroxidation; Male; Mice; Multiple Organ Failure; Nitric Oxide; Nitrosation; Rosiglitazone; Shock; Thiazolidinediones; Zymosan

2004
Hyperbaric oxygen therapy prevents vascular derangement during zymosan-induced multiple-organ-failure syndrome.
    Intensive care medicine, 2004, Volume: 30, Issue:6

    Topics: Analysis of Variance; Animals; Aorta; Endothelium, Vascular; Hyperbaric Oxygenation; Immunohistochemistry; Male; Malondialdehyde; Multiple Organ Failure; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Random Allocation; Rats; Rats, Sprague-Dawley; Tyrosine; Vascular Diseases; Vasodilation; Zymosan

2004
Treatment with a novel poly(ADP-ribose) glycohydrolase inhibitor reduces development of septic shock-like syndrome induced by zymosan in mice.
    Critical care medicine, 2004, Volume: 32, Issue:6

    Topics: Acute Disease; Amides; Animals; Glycoside Hydrolases; Interleukin-1; Male; Malondialdehyde; Mice; Mice, Inbred Strains; Multiple Organ Failure; Peritonitis; Peroxidase; Shock, Septic; Tannins; Tumor Necrosis Factor-alpha; Zymosan

2004
Tissue- and time-dependent upregulation of cytokine mRNA in a murine model for the multiple organ dysfunction syndrome.
    Annals of surgery, 2004, Volume: 240, Issue:1

    Topics: Animals; Cytokines; Escherichia coli; Interferon-gamma; Interleukins; Kidney; Lipopolysaccharides; Liver; Lung; Mice; Mice, Inbred C57BL; Multiple Organ Failure; Peritonitis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spleen; Time Factors; Tumor Necrosis Factor-alpha; Up-Regulation; Zymosan

2004
Role of 5-lipoxygenase in the multiple organ failure induced by zymosan.
    Intensive care medicine, 2004, Volume: 30, Issue:10

    Topics: Animals; Arachidonate 5-Lipoxygenase; Lipid Peroxidation; Male; Mice; Mice, Knockout; Models, Animal; Multiple Organ Failure; Nitric Oxide; Peritonitis; Random Allocation; Syndrome; Zymosan

2004
Increased expression of matrix metalloproteinases in the murine zymosan-induced multiple organ dysfunction syndrome.
    The Journal of pathology, 2004, Volume: 203, Issue:4

    Topics: Animals; Immunoenzyme Techniques; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Multiple Organ Failure; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Up-Regulation; Zymosan

2004
Chemiluminescence: comparison of whole blood with isolated polymorphonuclear leukocytes after major trauma.
    The Journal of trauma, 2004, Volume: 57, Issue:2

    Topics: Case-Control Studies; Cell Separation; Disease Progression; Humans; Inflammation; Injury Severity Score; Luminescent Measurements; Macrophage-1 Antigen; Multiple Organ Failure; Multiple Trauma; NADP; Neutrophil Activation; Neutrophils; Patient Selection; Predictive Value of Tests; Reactive Oxygen Species; Respiratory Burst; Respiratory Distress Syndrome; Risk Factors; Statistics, Nonparametric; Tetradecanoylphorbol Acetate; Time Factors; Zymosan

2004
Increased activity of the intestinal mucosal mast cells in rats with multiple organ failure.
    Chinese journal of digestive diseases, 2004, Volume: 5, Issue:2

    Topics: Animals; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Fluorometry; Histamine; Immunohistochemistry; Intestinal Mucosa; Multiple Organ Failure; Rats; Tumor Necrosis Factor-alpha; Zymosan

2004
Pentoxifylline does not improve outcome in a murine model for the multiple-organ dysfunction syndrome.
    Intensive care medicine, 2005, Volume: 31, Issue:5

    Topics: Animals; Cells, Cultured; Cytokines; Dose-Response Relationship, Drug; Double-Blind Method; Mice; Mice, Inbred C57BL; Multiple Organ Failure; Pentoxifylline; Random Allocation; Survival Analysis; Vasodilator Agents; Zymosan

2005
The effects of selective nitric oxide synthase blocker on survival, mesenteric blood flow and multiple organ failure induced by zymosan.
    The Journal of surgical research, 2005, Volume: 124, Issue:1

    Topics: Animals; beta-Glucans; Enzyme Inhibitors; Guanidines; Kidney; Liver; Lung; Mice; Multiple Organ Failure; Nitric Oxide Synthase; Splanchnic Circulation; Spleen; Survival Analysis; Zymosan

2005
Modeling MODS: what can be learned from animal models of the multiple-organ dysfunction syndrome?
    Intensive care medicine, 2005, Volume: 31, Issue:5

    Topics: Animals; Disease Models, Animal; Immunologic Factors; Mice; Multiple Organ Failure; Pentoxifylline; PPAR gamma; Prostaglandin D2; Vasodilator Agents; Zymosan

2005
Altered chemokine response in an animal model of multiple organ dysfunction syndrome induced by zymosan.
    Journal of pediatric surgery, 2005, Volume: 40, Issue:3

    Topics: Animals; Ascitic Fluid; Bronchoalveolar Lavage Fluid; Chemokine CCL2; Chemokines; Disease Models, Animal; Injections, Intraperitoneal; Male; Multiple Organ Failure; Peritonitis; Random Allocation; Rats; Rats, Sprague-Dawley; Zymosan

2005
Amelioration of the development of multiple organ dysfunction syndrome by somatostatin via suppression of intestinal mucosal mast cells.
    Shock (Augusta, Ga.), 2005, Volume: 23, Issue:5

    Topics: Animals; Dose-Response Relationship, Drug; Histamine; Hormones; In Vitro Techniques; Intestinal Mucosa; Intestines; Male; Mast Cells; Microscopy, Electron; Multiple Organ Failure; Peptides; Polymerase Chain Reaction; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Somatostatin; Time Factors; Tumor Necrosis Factor-alpha; Zymosan

2005
The cyclopentenone prostaglandin 15-deoxydelta(12,14)-prostaglandin J2 attenuates the development of zymosan-induced shock.
    Intensive care medicine, 2005, Volume: 31, Issue:5

    Topics: Analysis of Variance; Animals; Animals, Outbred Strains; Immunohistochemistry; Immunologic Factors; Male; Mice; Multiple Organ Failure; Nitric Oxide; Peroxynitrous Acid; PPAR gamma; Prostaglandin D2; Random Allocation; Zymosan

2005
[Relationship between glomerular lesion and NF-kappaB p65 activity in rat multiple organ failure caused by zymosan].
    Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology, 2005, Volume: 21, Issue:4

    Topics: Animals; Female; Hydrogen-Ion Concentration; Immunohistochemistry; Kidney Glomerulus; Multiple Organ Failure; Oxygen; Rats; Rats, Wistar; Transcription Factor RelA; Zymosan

2005
Dose-dependent improvements in outcome with adenoviral expression of interleukin-10 in a murine model of multisystem organ failure.
    Gene therapy, 2006, Volume: 13, Issue:3

    Topics: Acute Disease; Adenoviridae; Animals; Bacterial Infections; Dose-Response Relationship, Immunologic; Gene Expression; Gene Targeting; Genetic Therapy; Genetic Vectors; Humans; Immunotherapy, Active; Interleukin-10; Interleukin-6; Lung; Lung Diseases; Mice; Mice, Inbred C57BL; Models, Animal; Multiple Organ Failure; Polysaccharides, Bacterial; Recombinant Fusion Proteins; Survival Rate; Transduction, Genetic; Tumor Necrosis Factor-alpha; Zymosan

2006
A comparison of elderly and adult multiple organ dysfunction syndrome in the rat model.
    Experimental gerontology, 2006, Volume: 41, Issue:8

    Topics: Aging; Animals; Apoptosis; Body Weight; Bronchoalveolar Lavage Fluid; Calcium; Carbon Dioxide; Cytokines; Disease Models, Animal; Lung; Macrophages, Alveolar; Male; Multiple Organ Failure; Myocardium; Organ Size; Oxygen; Partial Pressure; Rats; Rats, Sprague-Dawley; Zymosan

2006
Protective effect of Hypericum perforatum in zymosan-induced multiple organ dysfunction syndrome: relationship to its inhibitory effect on nitric oxide production and its peroxynitrite scavenging activity.
    Nitric oxide : biology and chemistry, 2007, Volume: 16, Issue:1

    Topics: Animals; Hypericum; Immunohistochemistry; Intestines; Lung; Male; Mice; Multiple Organ Failure; Neutrophils; Nitric Oxide; Nitric Oxide Synthase Type II; Plant Extracts; Zymosan

2007
Polymorphonuclear leukocyte dysfunction syndrome in patients with increasing sepsis severity.
    Shock (Augusta, Ga.), 2006, Volume: 26, Issue:3

    Topics: C-Reactive Protein; Calcimycin; Calcitonin; CD18 Antigens; Humans; Hydrogen Peroxide; Interleukin-6; Leukocyte Count; Middle Aged; Multiple Organ Failure; N-Formylmethionine Leucyl-Phenylalanine; Neutrophil Activation; Neutrophils; Opsonin Proteins; Phagocytosis; Protein Precursors; Sepsis; Severity of Illness Index; Shock, Septic; Syndrome; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha; Zymosan

2006
Hyperbaric oxygen therapy prevents coagulation disorders in an experimental model of multiple organ failure syndrome.
    Intensive care medicine, 2006, Volume: 32, Issue:11

    Topics: Animals; Blood Coagulation Disorders; Hyperbaric Oxygenation; Male; Multiple Organ Failure; Random Allocation; Rats; Rats, Sprague-Dawley; Survival Analysis; Zymosan

2006
Absence of peroxisome proliferators-activated receptors (PPAR)alpha enhanced the multiple organ failure induced by zymosan.
    Shock (Augusta, Ga.), 2006, Volume: 26, Issue:5

    Topics: Animals; Apoptosis; Fas Ligand Protein; Inflammation; Intestines; Kidney; Lipid Peroxidation; Mice; Mice, Knockout; Multiple Organ Failure; Neutrophil Infiltration; Nitric Oxide; PPAR alpha; Shock; Tumor Necrosis Factor-alpha; Tyrosine; Up-Regulation; Zymosan

2006
Beneficial effects of erythropoietin in preclinical models of shock and organ failure.
    Critical care (London, England), 2007, Volume: 11, Issue:3

    Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Endotoxemia; Erythropoietin; Mice; Multiple Organ Failure; Shock; Shock, Hemorrhagic; Shock, Septic; Spinal Cord Injuries; Treatment Outcome; Zymosan

2007
[Implications of lung interstitial dendritic cells of mice in multiple organ dysfunction syndrome].
    Zhonghua bing li xue za zhi = Chinese journal of pathology, 2007, Volume: 36, Issue:5

    Topics: Animals; Antigens, CD; B7-1 Antigen; B7-2 Antigen; CD11c Antigen; CD4-CD8 Ratio; Cell Proliferation; Chemokine CCL21; Dendritic Cells; Disease Models, Animal; Lectins, C-Type; Male; Mice; Mice, Inbred C57BL; Minor Histocompatibility Antigens; Multiple Organ Failure; Random Allocation; Receptors, CCR7; Receptors, Cell Surface; Zymosan

2007
Etanercept reduces acute tissue injury and mortality associated to zymosan-induced multiple organ dysfunction syndrome.
    Shock (Augusta, Ga.), 2008, Volume: 29, Issue:5

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; bcl-2-Associated X Protein; Etanercept; Fas Ligand Protein; Immunoglobulin G; Inflammation; Mice; Mice, Knockout; Multiple Organ Failure; Peritonitis; Proto-Oncogene Proteins c-bcl-2; Receptors, Tumor Necrosis Factor; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Zymosan

2008
Absence of endogenous interleukin-10 enhanced organ dysfunction and mortality associated to zymosan-induced multiple organ dysfunction syndrome.
    Cytokine, 2008, Volume: 41, Issue:2

    Topics: Animals; Gene Deletion; Interleukin-10; Interleukin-1beta; Kidney; Lipid Peroxidation; Liver; Mice; Mice, Knockout; Multiple Organ Failure; Neutrophil Infiltration; Nitrates; Nitrites; Pancreas; Peritonitis; Tumor Necrosis Factor-alpha; Zymosan

2008
Volatile anesthetic modulation of lung injury and outcome in a murine model of multiple organ dysfunction syndrome.
    Shock (Augusta, Ga.), 1995, Volume: 4, Issue:1

    Topics: Anesthetics, Inhalation; Animals; Disease Models, Animal; Mice; Multiple Organ Failure; Peroxidase; Respiratory Distress Syndrome; Treatment Outcome; Zymosan

1995
Deficiency of complement factor C5 reduces early mortality but does not prevent organ damage in an animal model of multiple organ dysfunction syndrome.
    Critical care medicine, 1995, Volume: 23, Issue:10

    Topics: Aging; Animals; Complement Activation; Complement C5; Disease Models, Animal; Injections, Intraperitoneal; Male; Mice; Multiple Organ Failure; Organ Size; Zymosan

1995
[Evaluation of an experimental model of multiple organ dysfunction].
    Minerva anestesiologica, 1994, Volume: 60, Issue:4

    Topics: Animals; Disease Models, Animal; Lung; Male; Multiple Organ Failure; Organ Size; Rats; Rats, Wistar; Survival Rate; Tomography, X-Ray Computed; Zymosan

1994
The gut: a cytokine-generating organ in systemic inflammation?
    Shock (Augusta, Ga.), 1995, Volume: 4, Issue:3

    Topics: Analysis of Variance; Animals; Bacterial Translocation; Cytokines; Intestinal Mucosa; Intestines; Male; Multiple Organ Failure; Rats; Rats, Sprague-Dawley; Zymosan

1995
Inflammatory cytokines in an experimental model for the multiple organ dysfunction syndrome.
    Critical care medicine, 1996, Volume: 24, Issue:7

    Topics: Animals; Cytokines; Disease Models, Animal; In Vitro Techniques; Inflammation; Interleukin-1; Interleukin-6; Lipopolysaccharides; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Multiple Organ Failure; Tumor Necrosis Factor-alpha; Zymosan

1996
Aprotinin prevents the development of the trauma-induced multiple organ failure in a chronic sheep model.
    European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies, 1996, Volume: 34, Issue:3

    Topics: Animals; Aprotinin; Capillary Permeability; Disease Models, Animal; Endotoxins; Escherichia coli; Female; Femoral Artery; Heart; Hemodynamics; Hemorrhage; Hemostatics; Kidney; L-Lactate Dehydrogenase; Leukocyte Count; Liver; Lung; Multiple Organ Failure; Neutrophils; Serine Proteinase Inhibitors; Sheep; Wounds and Injuries; Zymosan

1996
Increasing cytotoxic activity and production of reactive oxygen and nitrogen intermediates by peritoneal macrophages during the development of multiple organ dysfunction syndrome in mice.
    Scandinavian journal of immunology, 1996, Volume: 44, Issue:4

    Topics: Animals; Antibody-Dependent Cell Cytotoxicity; Cytotoxicity, Immunologic; Disease Models, Animal; Inflammation; Macrophage Activation; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Multiple Organ Failure; Nitric Oxide; Phagocytosis; Superoxides; Syndrome; Zymosan

1996
Organ damage is preceded by changes in protein extravasation in an experimental model of multiple organ dysfunction syndrome.
    Shock (Augusta, Ga.), 1997, Volume: 7, Issue:2

    Topics: Animals; Body Fluid Compartments; Body Temperature; Body Weight; Capillary Permeability; Disease Models, Animal; Extracellular Space; Male; Mice; Mice, Inbred C57BL; Multiple Organ Failure; Proteins; Zymosan

1997
Two chemotactic factors, C5a and MIP-1alpha, dramatically alter the mortality from zymosan-induced multiple organ dysfunction syndrome (MODS): C5a contributes to MODS while MIP-1alpha has a protective role.
    Molecular immunology, 1996, Volume: 33, Issue:14

    Topics: Animals; Chemical and Drug Induced Liver Injury; Chemokine CCL3; Chemokine CCL4; Chemotactic Factors; Complement C5a; Female; Heart Diseases; Liver Diseases; Lung Diseases; Lymphatic Diseases; Macrophage Inflammatory Proteins; Male; Mice; Mice, Knockout; Multiple Organ Failure; Syndrome; Zymosan

1996
Elimination of various subpopulations of macrophages and the development of multiple-organ dysfunction syndrome in mice.
    Archives of surgery (Chicago, Ill. : 1960), 1997, Volume: 132, Issue:5

    Topics: Animals; Clodronic Acid; Drug Carriers; Liposomes; Macrophages; Male; Mice; Mice, Inbred C57BL; Multiple Organ Failure; Organ Size; Zymosan

1997
Inhibition of poly (ADP-ribose) synthetase attenuates neutrophil recruitment and exerts antiinflammatory effects.
    The Journal of experimental medicine, 1997, Oct-06, Volume: 186, Issue:7

    Topics: Animals; Benzamides; Carrageenan; Cell Movement; Edema; Enzyme Inhibitors; Histocytochemistry; Inflammation; Lung; Male; Mice; Mice, Knockout; Multiple Organ Failure; Neutrophils; Peritonitis; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Rats; Rats, Wistar; Zymosan

1997
Multiple organ failure following zymosan-induced peritonitis is mediated by nitric oxide.
    Shock (Augusta, Ga.), 1997, Volume: 8, Issue:4

    Topics: Acute Disease; Animals; Disease Models, Animal; Enzyme Induction; Injections, Intraperitoneal; Male; Multiple Organ Failure; Nitric Oxide; Nitric Oxide Synthase; Peritonitis; Random Allocation; Rats; Rats, Sprague-Dawley; Zymosan

1997
Gradual development of organ damage in the murine zymosan-induced multiple organ dysfunction syndrome.
    Shock (Augusta, Ga.), 1997, Volume: 8, Issue:4

    Topics: Animals; Disease Models, Animal; Disease Progression; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Multiple Organ Failure; Organ Size; Survival Rate; Time Factors; Zymosan

1997
Chlorpromazine down-regulates tumor necrosis factor-alpha and attenuates experimental multiple organ dysfunction syndrome in mice.
    Critical care medicine, 1998, Volume: 26, Issue:7

    Topics: Animals; Chlorpromazine; Disease Models, Animal; Down-Regulation; Drug Administration Schedule; Immunologic Factors; Male; Mice; Mice, Inbred C57BL; Multiple Organ Failure; Prospective Studies; Random Allocation; Tumor Necrosis Factor-alpha; Zymosan

1998
Multiple organ failure (MOF) after severe trauma--a sheep model.
    Intensive care medicine, 1998, Volume: 24, Issue:6

    Topics: Albumins; Animals; Bronchoalveolar Lavage Fluid; Capillary Permeability; Disease Models, Animal; Disease Progression; Endotoxins; Female; Femur; Fracture Fixation, Intramedullary; Heart Function Tests; Least-Squares Analysis; Leukocyte Count; Liver; Lung; Multiple Organ Failure; Multiple Trauma; Sheep; Shock; Zymosan

1998
Interleukin-10 reduces morbidity and mortality in murine multiple organ dysfunction syndrome (MODS).
    The Journal of surgical research, 1998, Jul-01, Volume: 77, Issue:2

    Topics: Animals; Disease Models, Animal; Disease Progression; Interleukin-10; Male; Mice; Mice, Inbred ICR; Multiple Organ Failure; Specific Pathogen-Free Organisms; Survival Analysis; Zymosan

1998
A monoclonal antibody against tumour necrosis factor-alpha improves survival in experimental multiple organ dysfunction syndrome.
    Cytokine, 1998, Volume: 10, Issue:11

    Topics: Animals; Antibodies, Monoclonal; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Multiple Organ Failure; Survival Analysis; Tumor Necrosis Factor-alpha; Zymosan

1998
Role of interleukin-6 in a non-septic shock model induced by zymosan.
    European cytokine network, 1999, Volume: 10, Issue:2

    Topics: Animals; Antibodies, Monoclonal; Ascites; Ascitic Fluid; DNA Damage; Energy Metabolism; Injections, Intraperitoneal; Interleukin-6; Intestine, Small; Leukocyte Count; Lipid Peroxidation; Liver; Lung; Macrophage Activation; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Mice, Knockout; Multiple Organ Failure; NAD; Neutrophils; Nitrates; Nitrites; Oxidative Phosphorylation; Peritonitis; Peroxidase; Shock; Tyrosine; Zymosan

1999
Protective effect of N-acetylcysteine on multiple organ failure induced by zymosan in the rat.
    Critical care medicine, 1999, Volume: 27, Issue:8

    Topics: Acetylcysteine; Animals; Body Weight; Disease Models, Animal; Drug Evaluation, Preclinical; Free Radical Scavengers; Leukocyte Count; Male; Multiple Organ Failure; Nitrates; Nitric Oxide; Peritonitis; Random Allocation; Rats; Rats, Sprague-Dawley; Shock, Septic; Survival Analysis; Time Factors; Zymosan

1999
Protective effect of poly(ADP-ribose) synthetase inhibition on multiple organ failure after zymosan-induced peritonitis in the rat.
    Critical care medicine, 1999, Volume: 27, Issue:8

    Topics: Animals; Benzamides; Body Weight; Disease Models, Animal; Drug Evaluation, Preclinical; Male; Multiple Organ Failure; Niacinamide; Nitrates; Peritonitis; Poly(ADP-ribose) Polymerase Inhibitors; Random Allocation; Rats; Rats, Sprague-Dawley; Time Factors; Zymosan

1999
Interleukin 10 mitigates the development of the zymosan-induced multiple organ dysfunction syndrome in mice.
    Cytokine, 1999, Volume: 11, Issue:9

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Cytokines; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Gene Expression Regulation; Hemorrhage; Humans; Hypothermia; Interleukin-10; Lipopolysaccharides; Liver; Lung; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Multiple Organ Failure; Organ Size; Recombinant Proteins; Spleen; Tumor Necrosis Factor-alpha; Zymosan

1999
Elucidation of the early events contributing to zymosan-induced multiple organ dysfunction syndrome using MIP-1alpha, C3 knockout, and C5-deficient mice.
    Shock (Augusta, Ga.), 1999, Volume: 12, Issue:5

    Topics: Animals; Chemokine CCL3; Chemokine CCL4; Complement Activation; Complement C3; Complement C5; Disease Models, Animal; Exudates and Transudates; Injections, Intraperitoneal; Kidney; Leukocyte Count; Lung; Macrophage Inflammatory Proteins; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Knockout; Mice, Mutant Strains; Multiple Organ Failure; Myocardium; Neutrophil Infiltration; Peritonitis; Spleen; Transaminases; Zymosan

1999
Role of hyperbaric oxygen exposure in reduction of lipid peroxidation and in multiple organ failure induced by zymosan administration in the rat.
    Shock (Augusta, Ga.), 2000, Volume: 13, Issue:3

    Topics: Animals; Hyperbaric Oxygenation; Lipid Peroxidation; Male; Malondialdehyde; Multiple Organ Failure; Peritonitis; Peroxidase; Rats; Rats, Sprague-Dawley; Tyrosine; Zymosan

2000
A comparison of neonatal and adult multiorgan failure in a rat model.
    Journal of pediatric surgery, 2000, Volume: 35, Issue:3

    Topics: Age Factors; Animals; Animals, Newborn; Disease Models, Animal; Disease Progression; Kidney; Liver; Lung; Male; Multiple Organ Failure; Organ Size; Rats; Rats, Sprague-Dawley; Spleen; Surgical Procedures, Operative; Zymosan

2000
The role of tumor necrosis factor in the development of multiple organ failure in a murine model.
    Critical care medicine, 2000, Volume: 28, Issue:6

    Topics: Animals; Bronchoalveolar Lavage Fluid; Mice; Mice, Inbred C57BL; Multiple Organ Failure; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha; Zymosan

2000
Chronic type IV phosphodiesterase inhibition protects glomerular filtration rate and renal and mesenteric blood flow in a zymosan-induced model of multiple organ dysfunction syndrome treated with norepinephrine.
    The Journal of pharmacology and experimental therapeutics, 2001, Volume: 296, Issue:1

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adrenergic alpha-Agonists; Animals; Blood Pressure; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Glomerular Filtration Rate; Heart Rate; Hemodynamics; Male; Multiple Organ Failure; Norepinephrine; Phosphodiesterase Inhibitors; Random Allocation; Rats; Rats, Sprague-Dawley; Renal Circulation; Splanchnic Circulation; Vascular Resistance; Zymosan

2001
Beneficial effects of tempol, a membrane-permeable radical scavenger, on the multiple organ failure induced by zymosan in the rat.
    Critical care medicine, 2001, Volume: 29, Issue:1

    Topics: Analysis of Variance; Animals; Cyclic N-Oxides; Free Radical Scavengers; In Vitro Techniques; Intestine, Small; Liver; Lung; Male; Multiple Organ Failure; Poly(ADP-ribose) Polymerases; Random Allocation; Rats; Rats, Sprague-Dawley; Spin Labels; Statistics, Nonparametric; Tyrosine; Zymosan

2001
Tempering the temptation to treat with tempol.
    Critical care medicine, 2001, Volume: 29, Issue:1

    Topics: Animals; Antioxidants; Cyclic N-Oxides; Disease Models, Animal; Humans; Multiple Organ Failure; Rats; Shock, Septic; Spin Labels; Zymosan

2001
Inducible nitric oxide synthase knockout mice exhibit resistance to the multiple organ failure induced by zymosan.
    Shock (Augusta, Ga.), 2001, Volume: 16, Issue:1

    Topics: Animals; Enzyme Inhibitors; Exudates and Transudates; Guanidines; Lipid Peroxidation; Liver; Lung; Macrophages, Peritoneal; Male; Mice; Mice, Knockout; Multiple Organ Failure; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Peritonitis; Peroxidase; Poly(ADP-ribose) Polymerases; Rhodamines; Shock; Tyrosine; Zymosan

2001
The involvement of multiple protease-antiprotease systems and gut origin sepsis in zymosan-associated endothelial barrier injury and multiple organ dysfunction in rats.
    Shock (Augusta, Ga.), 2001, Volume: 16, Issue:4

    Topics: Animals; Bacterial Translocation; Body Fluids; Dose-Response Relationship, Drug; Endopeptidases; Endothelium; Injections, Intraperitoneal; Male; Multiple Organ Failure; Permeability; Protease Inhibitors; Random Allocation; Rats; Rats, Sprague-Dawley; Zymosan

2001
[Protective effects of tongli gongxia herbs on gut barrier in rat with multiple organ dysfunction syndrome].
    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2000, Volume: 20, Issue:2

    Topics: Amine Oxidase (Copper-Containing); Animals; Bacterial Translocation; Drugs, Chinese Herbal; Endotoxins; Female; Male; Multiple Organ Failure; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Zymosan

2000
Improved survival of TNF-deficient mice during the zymosan-induced multiple organ dysfunction syndrome.
    Shock (Augusta, Ga.), 2002, Volume: 17, Issue:6

    Topics: Animals; Liver; Lung; Lymphotoxin-alpha; Mice; Mice, Knockout; Multiple Organ Failure; Organ Size; Spleen; Tumor Necrosis Factor-alpha; Zymosan

2002
The tyrosine kinase inhibitor tyrphostin AG 126 reduces the multiple organ failure induced by zymosan in the rat.
    Intensive care medicine, 2002, Volume: 28, Issue:6

    Topics: Animals; Enzyme Inhibitors; Male; Models, Animal; Multiple Organ Failure; Nitric Oxide; Peritonitis; Protein-Tyrosine Kinases; Rats; Rats, Sprague-Dawley; Tyrphostins; Zymosan

2002
Superoxide dismutase and catalase in an experimental model of multiple organ failure.
    The Journal of surgical research, 1992, Volume: 52, Issue:3

    Topics: Animals; Catalase; Disease Models, Animal; Free Radical Scavengers; Lipid Peroxidation; Male; Multiple Organ Failure; Rats; Rats, Inbred Strains; Superoxide Dismutase; Zymosan

1992
[Rat multiple organ failure model caused by zymosan injections: a pathomorphological study].
    Zhonghua wai ke za zhi [Chinese journal of surgery], 1991, Volume: 29, Issue:7

    Topics: Animals; Disease Models, Animal; Male; Microscopy, Electron; Multiple Organ Failure; Rats; Rats, Inbred Strains; Reference Standards; Zymosan

1991
[Pathological changes in immune defense system of multiple-organ failure rat and their action on pathogenesis].
    Zhonghua wai ke za zhi [Chinese journal of surgery], 1991, Volume: 29, Issue:11

    Topics: Animals; Fibronectins; Male; Multiple Organ Failure; Phagocytes; Rats; Rats, Inbred Strains; Spleen; Thymus Gland; Zymosan

1991
Does selective decontamination of the gastrointestinal tract prevent multiple organ failure? An experimental study.
    Archives of surgery (Chicago, Ill. : 1960), 1991, Volume: 126, Issue:5

    Topics: Animals; Digestive System; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Lymph Nodes; Male; Mesentery; Multiple Organ Failure; Peritonitis; Rats; Rats, Inbred Strains; Streptomycin; Survival Rate; Trimethoprim; Zymosan

1991
Protein malnutrition predisposes to inflammatory-induced gut-origin septic states.
    Annals of surgery, 1990, Volume: 211, Issue:5

    Topics: Animals; Bacteria; Blood; Female; Infections; Inflammation; Intestinal Mucosa; Intestines; Liver; Male; Mice; Multiple Organ Failure; Protein-Energy Malnutrition; Respiratory Distress Syndrome; Spleen; Time Factors; Zymosan

1990
SOD in rat models of shock and organ failure.
    Advances in experimental medicine and biology, 1990, Volume: 264

    Topics: Animals; Body Weight; Cattle; Disease Models, Animal; Lipid Peroxidation; Liver; Male; Multiple Organ Failure; Peritonitis; Rats; Rats, Inbred Strains; Shock; Shock, Septic; Superoxide Dismutase; Zymosan

1990
Neutrophil function and lipid peroxidation in a rat model of multiple organ failure.
    The Journal of surgical research, 1989, Volume: 47, Issue:6

    Topics: Alanine Transaminase; Animals; Lipid Peroxides; Liver; Lung; Male; Multiple Organ Failure; Neutrophils; Organ Size; Rats; Rats, Inbred Strains; Superoxides; Zymosan

1989
Development of a bacteria-independent model of the multiple organ failure syndrome.
    Archives of surgery (Chicago, Ill. : 1960), 1989, Volume: 124, Issue:12

    Topics: Animals; Bacteria; Disease Models, Animal; Hemodynamics; Intestines; Kidney; Liver; Lung; Lymph Nodes; Mineral Oil; Multiple Organ Failure; Rats; Rats, Inbred Strains; Respiration; Sepsis; Zymosan

1989
Endotoxin does not play a key role in the pathogenesis of multiple organ failure. An experimental study.
    Progress in clinical and biological research, 1989, Volume: 308

    Topics: Animals; Body Temperature; Body Weight; Endotoxins; Escherichia coli; Hemorrhage; Lung; Lung Diseases; Male; Mice; Mice, Inbred C3H; Multiple Organ Failure; Organ Size; Spleen; Staphylococcus; Zymosan

1989
Leukocyte induced pulmonary damage using intraperitoneal zymosan.
    Progress in clinical and biological research, 1989, Volume: 308

    Topics: Animals; Cell Aggregation; Injections, Intraperitoneal; Leukocytes; Lung; Lung Diseases; Malondialdehyde; Multiple Organ Failure; Rabbits; Vitamin E; Zymosan

1989
Complement activation in peritonitis. Association with hepatic and renal perfusion abnormalities. First place winner: Conrad Jobst award.
    The American surgeon, 1987, Volume: 53, Issue:12

    Topics: Animals; Complement Activation; Elapid Venoms; Female; Liver Circulation; Male; Multiple Organ Failure; Peritonitis; Rats; Rats, Inbred Strains; Renal Circulation; Time Factors; Vascular Resistance; Zymosan

1987
Multiple-organ failure and sepsis without bacteria. An experimental model.
    Archives of surgery (Chicago, Ill. : 1960), 1986, Volume: 121, Issue:8

    Topics: Animals; Blood Chemical Analysis; Disease Models, Animal; Germ-Free Life; Leukocyte Count; Male; Multiple Organ Failure; Organ Size; Paraffin; Rats; Rats, Inbred Strains; Zymosan

1986
Polydatin: a new therapeutic agent against multiorgan dysfunction.
    The Journal of surgical research, 2015, Volume: 198, Issue:1

    Topics: Animals; Caspase 3; Cytokines; Female; Glucosides; Multiple Organ Failure; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Stilbenes

2015
[Pharmacological intervention in experimental multiple organ failure in rats].
    Zhonghua zheng xing shao shang wai ke za zhi = Zhonghua zheng xing shao shang waikf [i.e. waike] zazhi = Chinese journal of plastic surgery and burns, 1992, Volume: 8, Issue:1

    Topics: Allopurinol; Animals; Antioxidants; Free Radicals; Fructose-Bisphosphatase; Glucosides; Glutathione Peroxidase; Male; Malondialdehyde; Multiple Organ Failure; Oxygen; Rats; Rats, Inbred Strains; Stilbenes; Superoxide Dismutase

1992